PDS Biotechnology GAAP EPS of -$0.21 beats by $0.02

1 hour ago 1

PDS Biotechnology press release (NASDAQ:PDSB): Q2 GAAP EPS of -$0.21 beats by $0.02.
The Company’s cash balance as of June 30, 2025 was $31.9 million, compared to $41.7 million as of December 31, 2024.

Recommended For You